BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August

Day

• 1
• 2
• 3
• 4
• 5
• 7
• 8
• 9
• 10
• 11
• 12
• 14
• 15
• 16
• 17
• 18
• 19
• 21
• 22
• 23
• 24
• 25
• 26
• 28
• 29
• 30

• Press Releases

  Castle Biosciences’ TissueCypher® Test Surpasses 100,000 Orders, Advancing Precision Risk Assessment for Patients with Barrett’s Esophagus

  June 16, 2026

   · 

  6 min read
• Press Releases

  DIMERIX EXCLUSIVELY LICENSES DMX-200 IN GREATER CHINA, SOUTH KOREA AND SOUTHEAST ASIA TO EVEREST MEDICINES

  June 16, 2026

   · 

  10 min read
• Press Releases

  Cizzle Bio Announces Laboratory Validation of CIZ1B Biomarker Blood Test for Early Lung Cancer at OmniHealth Diagnostics

  June 16, 2026

   · 

  4 min read
• Press Releases

  Edgewise Therapeutics Announces Positive Top-Line Data from 12-Week Phase 2 CIRRUS-HCM Trial with EDG-7500 in Obstructive and Nonobstructive Hypertrophic Cardiomyopathy (HCM)

  June 16, 2026

   · 

  10 min read
• Press Releases

  Syremis Therapeutics Appoints Dr. Aaron Koenig as Chief Medical Officer

  June 16, 2026

   · 

  2 min read
• Press Releases

  AccurKardia’s AK-AVS™ Aortic Valve Stenosis Screening Software Accepted into FDA Total Product Life Cycle Advisory Program

  June 16, 2026

   · 

  4 min read
• Press Releases

  Latus Bio Appoints Bethany Mancilla as Chief Business Officer

  June 16, 2026

   · 

  3 min read
• Press Releases

  Zai Lab Receives EMA Orphan Drug Designation for Zocilurtatug Pelitecan (Zoci) in Pulmonary Neuroendocrine Carcinomas

  June 16, 2026

   · 

  6 min read
• Press Releases

  Acumen Pharmaceuticals Announces Nomination of Two Enhanced Brain Delivery™ (EBD™) Development Candidates for the Treatment of Alzheimer’s Disease

  June 16, 2026

   · 

  7 min read
• Press Releases

  Cognition Therapeutics Announces New Composition of Matter Patent, Extending Patent Protection for Lead Candidate, Zervimesine (CT1812) Through 2045

  June 16, 2026

   · 

  7 min read